Search results
Royal Bank of Canada Increases Moderna (NASDAQ:MRNA) Price Target to $135.00
ETF DAILY NEWS· 14 hours agoRoyal Bank of Canada’s target price would indicate a potential upside of 8.00% from the stock’s previous close. Canaccord Genuity Group boosted their price objective on < ...
Mission Wealth Management LP Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 13 hours agoThe fund bought 2,063 shares of the company’s stock, valued at approximately $205,000. Allworth Financial LP increased its position in Moderna by 6.5% in ...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 3 days agoNormally, investors wouldn't reward such declines and steep shortfalls. But the market was braced for a notably worse showing. On average, analysts...
Largest U.S. Pension Sold Verizon, Disney, and Peloton Stock. It Bought Moderna.
Barrons.com· 13 hours agoModerna in the past week reported a strong first quarter, and investor focus is now set on a...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 3 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 3 days agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 3 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 3 days agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 3 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...